Public Health Perspectives on Hearing Loss and Aging Outcomes: The Association of Vision,Hearing, and Dual-Sensory Loss with Walking Speed and Incident Slow Walking: Longitudinal and Time to Event Analyses in the Health and Retirement Study

With the aging of the population, vision (VL), hearing (HL), and dual-sensory (DSL, concurrent VL and HL) loss will likely constitute important public health challenges. Walking speed is an indicator of functional status and is associated with mortality. Using the Health and Retirement Study, a nationally representative U.S. cohort, we analyzed the longitudinal relationship between sensory loss and walking speed. In multivariable mixed effects linear models, baseline walking speed was slower by 0.05 m/s (95% confidence interval [CI] = 0.04–0.07) for VL, 0.02 (95% CI = 0.003–0.03) for HL, and 0.07 (95% CI = 0.05–0.08) for DSL compared with those without sensory loss. Similar annual declines in walking speeds occurred in all groups. In time-to-event analyses, the risk of incident slow walking speed (walking speed < 0.6 m/s) was 43% (95% CI = 25–65%), 29% (95% CI = 13–48%), and 35% (95% CI = 13–61%) higher among those with VL, HL, and DSL respectively, relative to those without sensory loss. The risk of incident very slow walking speed (walking speed < 0.4 m/s) was significantly higher among those with HL and DSL relative to those without sensory loss, and significantly higher among those with DSL relative to those with VL or HL alone. Addressing sensory loss and teaching compensatory strategies may help mitigate the effect of sensory loss on walking speed.     

Is permethrin 5% cream effective for rosacea?

Permethrin 5% cream is a safe alternative for the topical treatment of papulopustular rosacea. Permethrin 5% cream is superior to metronidazole 0.75% gel and placebo in decreasing Demodex folliculorum, and is as effective as metronidazole 0.75% gel in treating erythema and papules.     

Leveraging Electronic Health Records to Identify and Characterize Patients with Low Vision

Purpose: To use electronic health record (EHR) data to estimate the prevalence and characteristics of low-vision (LV) patients.

Methods: EHR data were obtained for all patients at the nine clinical locations of the Wilmer Eye Institute in 2014. LV status at each visit was defined as visual acuity (VA) worse than 20/40 in the better-seeing eye. Prevalence and incidence estimates were determined over a 12-month period. Demographic and clinical data were used to compare the characteristics of patients with and without LV. Logistic regression analyses were used to determine prevalence and incidence estimates adjusted for age, sex, race, and ethnicity.

Results: A total of 100,755 patients were included in the analysis. There were 7752 (7.7%) prevalent and 1962 (2.1%) incident cases of LV. Among patients with LV, 55% had VA between 20/40 and 20/60. Outside of LV clinics, retina and glaucoma clinics had the highest prevalence (18% and 14%, respectively) and incidence (5% and 4%, respectively) of LV. The urban hospital center had twice the prevalence of LV than suburban clinics (11.5% vs. 5.6%). The odds of prevalent LV was greatest among patients 80 years and older (odds ratio = 6.18; 95% confidence interval: 5.62–6.80) as compared to those 20–39 years old.

Conclusions: EHR can be used to estimate the prevalence and describe the characteristics of patients with LV seeking ophthalmic care. The highest prevalence rates of LV are observed in the urban setting and among patients obtaining retina and glaucoma care.     

Low Vision Care – Out of Site. Out of Mind

ABSTRACT

Purpose

To estimate the number of patients accessing eye care with low vision (LV) at a large multi-site ophthalmology institute who utilize low vision rehabilitation (LVR) services and compare their characteristics to individuals who do not utilize LVR services.